0000820081-14-000005.txt : 20140220
0000820081-14-000005.hdr.sgml : 20140220
20140220153618
ACCESSION NUMBER: 0000820081-14-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140218
FILED AS OF DATE: 20140220
DATE AS OF CHANGE: 20140220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAMBREX CORP
CENTRAL INDEX KEY: 0000820081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222476135
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MEADOWLANDS PLZ
CITY: E RUTHERFORD
STATE: NJ
ZIP: 07073
BUSINESS PHONE: 2018043000
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: E. RUTHERFORD
STATE: NJ
ZIP: 07073
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SARGEN GREGORY
CENTRAL INDEX KEY: 0001227835
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10638
FILM NUMBER: 14629389
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-02-18
0000820081
CAMBREX CORP
CBM
0001227835
SARGEN GREGORY
ONE MEADOWLANDS PLAZA
EAST RUTHERFORD
NJ
07073
0
1
0
0
EVP & CFO
Common Stock
2014-02-18
4
M
0
8500
13.75
A
41819
D
Common Stock
2014-02-18
4
M
0
30000
5.51
A
71819
D
Common Stock
2014-02-18
4
S
0
38500
21.662
D
33319
D
Stock Option (Right to Buy)
13.75
2014-02-18
4
M
0
8500
0
D
2014-07-26
Common Stock
8500
0
D
Stock Option (Right to Buy)
5.51
2014-02-18
4
M
0
30000
0
D
2015-04-23
Common Stock
30000
50000
D
The option, representing a right to purchase a total of 8,500 shares, became exercisable in four equal annual installments beginning on July 26, 2008, which was the first anniversary of the date on which the option was granted.
The option, representing a right to purchase a total of 100,000 shares, became exercisable in four equal annual installments beginning on April 23, 2009, which was the first anniversary of the date on which the option was granted.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.45 to $21.86, inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
Linda Kresse for Gregory P. Sargen by POA
2014-02-20